MedCon 2024 to Convene April 24-26 in Columbus, Ohio

York, Pa., January 26, 2024 — The AFDO/RAPS Healthcare Products Collaborative has opened registration for the MedCon 2024 Conference. Main conference sessions will be held at the Hilton Columbus Downtown in Columbus, Ohio, from Wednesday, April 24 to Friday, April 26. On Tuesday, April 23, there will be a full-day workshop focused on machine learning in artificial intelligence (AIML) available for an additional fee. 

Since 2009, MedCon has united the healthcare products industry to work for a better tomorrow for patients. With a distinct focus on important issues that increase speed to market and product quality through innovation, the event brings together medical device regulators and industry experts from around the world for content-rich conference sessions that include uncommon collaboration, candid dialogue, and sharing.

“Last year’s event attracted more than 300 participants across 14 countries and five continents, including 42 participants from FDA,” said Timothy Hsu, Chief Collaboration Officer, AFDO/RAPS Healthcare Products Collaborative. “The Strategic Committee works throughout the year designing an agenda inspiring collaboration for some of the most powerful and innovative sessions meant to highlight the medical device industry’s significant conversations between manufacturers and regulators. I always look forward to MedCon, where this uncommon collaboration comes to life through the power of your participation and engagement. Join the discussion with participants from around the world, regulators, and medical device experts making a difference for the patients we serve.”

The MedCon 2024 program agenda features dynamic plenaries aimed at breaking barriers and solving problems, along with in-depth breakouts, updates from FDA, and Solutions Exchange sessions. Session topics for 2024 include cybersecurity risk management, global harmonization and convergence initiatives, the current state of biocompatibility, medical device sterilization sustainability, and international influences on a lifecycle risk management system. To view the current session and speaker lineup, visit https://healthcareproducts.org/medcon/2024-sessions/.

The MedCon Conference program is carefully curated by experts across the healthcare products industry to ensure the highest quality discussions, knowledge exchange, and collaboration opportunities. The MedCon 2024 Strategic Committee includes:

• Francis Blacha, Senior Vice President - Quality, Eli Lilly and Company
• Gert Bos, Executive Director & Partner, Qserve Group
• RADM Sean M. Boyd, Director, Office of Regulatory Programs, Office of Product Evaluation and Quality, FDA-CDRH
• Gina Brackett, OMDRHO Division 1 Director, Compliance Branch, FDA-ORA
• Bill Brodbeck, Senior Director, Regulatory Affairs, STERIS
• Aaron Dunbar, VP, Quality Systems & Post Market, Boston Scientific 
• Eric Henry, Senior Quality & Regulatory Compliance Advisor, FDA & Life Sciences Practice, King & Spalding
• Shannon Hoste, Senior Director of Human Factors & Regulatory Strategy, Agilis Consulting Group
• Timothy Hsu, Chief Collaboration Officer, AFDO/RAPS Healthcare Products Collaborative
• Susan Matthias, Consumer Safety Officer, Special Assistant in the Office of Medical Device and Radiological Health (OMDRHO)
• Phil Pontikos, National Device Expert, FDA-ORA
• Fatemeh Razjouyan, Director of Regulatory Policy, International and Harmonization | Global Regulatory Policy, Medtronic
• Heather Rosecrans, Executive Vice President, Medical Devices & Combination Products, Greenleaf Health, Inc.
• Kim Shoemaker, RAC, Senior Director, Global Regulatory Affairs, Ethicon
• Kim Trautman, Managing Director and Vice President, MEDIcept Inc.
• Monica Wilkins, Vice President Regulatory and Quality, Abbott
• Jessica Zeller, Vice President, Quality, Regulatory, Environmental, and Public Affairs Counsel, Edwards Lifesciences

Early registration is encouraged, and discounted rates are available until March 12, 2024. Complete event information can be reviewed at https://healthcareproducts.org/medcon/.

###

About the AFDO/RAPS Healthcare Products Collaborative

The AFDO/RAPS Healthcare Products Collaborative is a joint venture established in 2022 between the Association of Food and Drug Officials (AFDO) and the Regulatory Affairs Professionals Society (RAPS). Continuing and expanding upon Xavier Health's legacy, the Collaborative supports idea sharing, innovation, and action across the global healthcare products community by fostering purpose-driven discussions between regulators, industry, academia, and thought leaders about the most pressing issues facing the industry. The Collaborative's distinct events portfolio – which includes the MedCon Conference, AI Summit, Combination Products Summit, and PharmaLink Conference – highlights just one of the ways the partnership inspires collaboration. This unique blend of mission and values guides purpose-driven community building and innovative solutions to make a difference in patients’ lives. www.healthcareproducts.org